Cargando…

Sleep and circadian rhythm disruption by NPTX2 loss of function

Sleep and circadian rhythm disruption (SCRD) is commonly observed in aging, especially in individuals who experience progressive cognitive decline to mild cognitive impairment (MCI) and Alzheimer’s disease (AD). However, precise molecular mechanisms underlying the association between SCRD and aging...

Descripción completa

Detalles Bibliográficos
Autores principales: Roh, Seung-Eon, Xiao, Meifang, Delgado, Ana, Kwak, Chuljung, Savonenko, Alena, Bakker, Arnold, Kwon, Hyung-Bae, Worley, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10557648/
https://www.ncbi.nlm.nih.gov/pubmed/37808783
http://dx.doi.org/10.1101/2023.09.26.559408
_version_ 1785117130224566272
author Roh, Seung-Eon
Xiao, Meifang
Delgado, Ana
Kwak, Chuljung
Savonenko, Alena
Bakker, Arnold
Kwon, Hyung-Bae
Worley, Paul
author_facet Roh, Seung-Eon
Xiao, Meifang
Delgado, Ana
Kwak, Chuljung
Savonenko, Alena
Bakker, Arnold
Kwon, Hyung-Bae
Worley, Paul
author_sort Roh, Seung-Eon
collection PubMed
description Sleep and circadian rhythm disruption (SCRD) is commonly observed in aging, especially in individuals who experience progressive cognitive decline to mild cognitive impairment (MCI) and Alzheimer’s disease (AD). However, precise molecular mechanisms underlying the association between SCRD and aging are not fully understood. Orexin A is a well-characterized “sleep neuropeptide” that is expressed in hypothalamic neurons and evokes wake behavior. The importance of Orexin is exemplified in narcolepsy where it is profoundly down-regulated. Interestingly, the synaptic immediate early gene NPTX2 is co-expressed in Orexin neurons and is similarly reduced in narcolepsy. NPTX2 is also down-regulated in CSF of some cognitively normal older individuals and predicts the time of transition from normal cognition to MCI. The association between Orexin and NPTX2 is further evinced here where we observe that Orexin A and NPTX2 are highly correlated in CSF of cognitively normal aged individuals and raises the question of whether SCRD that are typically attributed to Orexin A loss of function may be modified by concomitant NPTX2 down-regulation. Is NPTX2 an effector of sleep or simply a reporter of orexin-dependent SCRD? To address this question, we examined NPTX2 KO mice and found they retain Orexin expression in the brain and so provide an opportunity to examine the specific contribution of NPTX2 to SCRD. Our results reveal that NPTX2 KO mice exhibit a disrupted circadian onset time, coupled with increased activity during the sleep phase, suggesting difficulties in maintaining states. Sleep EEG indicates distinct temporal allocation shifts across vigilance states, characterized by reduced wake and increased NREM time. Evident sleep fragmentation manifests through alterations of event occurrences during Wake and NREM, notably during light transition periods, in conjunction with an increased frequency of sleep transitions in NPTX2 KO mice, particularly between Wake and NREM. EEG spectral analysis indicated significant shifts in power across various frequency bands in the wake, NREM, and REM states, suggestive of disrupted neuronal synchronicity. An intriguing observation is the diminished occurrence of sleep spindles, one of the earliest measures of human sleep disruption, in NPTX2 KO mice. These findings highlight the effector role of NPTX2 loss of function as an instigator of SCRD and a potential mediator of sleep disruption in aging.
format Online
Article
Text
id pubmed-10557648
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cold Spring Harbor Laboratory
record_format MEDLINE/PubMed
spelling pubmed-105576482023-10-07 Sleep and circadian rhythm disruption by NPTX2 loss of function Roh, Seung-Eon Xiao, Meifang Delgado, Ana Kwak, Chuljung Savonenko, Alena Bakker, Arnold Kwon, Hyung-Bae Worley, Paul bioRxiv Article Sleep and circadian rhythm disruption (SCRD) is commonly observed in aging, especially in individuals who experience progressive cognitive decline to mild cognitive impairment (MCI) and Alzheimer’s disease (AD). However, precise molecular mechanisms underlying the association between SCRD and aging are not fully understood. Orexin A is a well-characterized “sleep neuropeptide” that is expressed in hypothalamic neurons and evokes wake behavior. The importance of Orexin is exemplified in narcolepsy where it is profoundly down-regulated. Interestingly, the synaptic immediate early gene NPTX2 is co-expressed in Orexin neurons and is similarly reduced in narcolepsy. NPTX2 is also down-regulated in CSF of some cognitively normal older individuals and predicts the time of transition from normal cognition to MCI. The association between Orexin and NPTX2 is further evinced here where we observe that Orexin A and NPTX2 are highly correlated in CSF of cognitively normal aged individuals and raises the question of whether SCRD that are typically attributed to Orexin A loss of function may be modified by concomitant NPTX2 down-regulation. Is NPTX2 an effector of sleep or simply a reporter of orexin-dependent SCRD? To address this question, we examined NPTX2 KO mice and found they retain Orexin expression in the brain and so provide an opportunity to examine the specific contribution of NPTX2 to SCRD. Our results reveal that NPTX2 KO mice exhibit a disrupted circadian onset time, coupled with increased activity during the sleep phase, suggesting difficulties in maintaining states. Sleep EEG indicates distinct temporal allocation shifts across vigilance states, characterized by reduced wake and increased NREM time. Evident sleep fragmentation manifests through alterations of event occurrences during Wake and NREM, notably during light transition periods, in conjunction with an increased frequency of sleep transitions in NPTX2 KO mice, particularly between Wake and NREM. EEG spectral analysis indicated significant shifts in power across various frequency bands in the wake, NREM, and REM states, suggestive of disrupted neuronal synchronicity. An intriguing observation is the diminished occurrence of sleep spindles, one of the earliest measures of human sleep disruption, in NPTX2 KO mice. These findings highlight the effector role of NPTX2 loss of function as an instigator of SCRD and a potential mediator of sleep disruption in aging. Cold Spring Harbor Laboratory 2023-09-27 /pmc/articles/PMC10557648/ /pubmed/37808783 http://dx.doi.org/10.1101/2023.09.26.559408 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which allows reusers to copy and distribute the material in any medium or format in unadapted form only, for noncommercial purposes only, and only so long as attribution is given to the creator.
spellingShingle Article
Roh, Seung-Eon
Xiao, Meifang
Delgado, Ana
Kwak, Chuljung
Savonenko, Alena
Bakker, Arnold
Kwon, Hyung-Bae
Worley, Paul
Sleep and circadian rhythm disruption by NPTX2 loss of function
title Sleep and circadian rhythm disruption by NPTX2 loss of function
title_full Sleep and circadian rhythm disruption by NPTX2 loss of function
title_fullStr Sleep and circadian rhythm disruption by NPTX2 loss of function
title_full_unstemmed Sleep and circadian rhythm disruption by NPTX2 loss of function
title_short Sleep and circadian rhythm disruption by NPTX2 loss of function
title_sort sleep and circadian rhythm disruption by nptx2 loss of function
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10557648/
https://www.ncbi.nlm.nih.gov/pubmed/37808783
http://dx.doi.org/10.1101/2023.09.26.559408
work_keys_str_mv AT rohseungeon sleepandcircadianrhythmdisruptionbynptx2lossoffunction
AT xiaomeifang sleepandcircadianrhythmdisruptionbynptx2lossoffunction
AT delgadoana sleepandcircadianrhythmdisruptionbynptx2lossoffunction
AT kwakchuljung sleepandcircadianrhythmdisruptionbynptx2lossoffunction
AT savonenkoalena sleepandcircadianrhythmdisruptionbynptx2lossoffunction
AT bakkerarnold sleepandcircadianrhythmdisruptionbynptx2lossoffunction
AT kwonhyungbae sleepandcircadianrhythmdisruptionbynptx2lossoffunction
AT worleypaul sleepandcircadianrhythmdisruptionbynptx2lossoffunction